467 related articles for article (PubMed ID: 15171418)
1. [Hypertension in patients with cardiac hypertrophy].
Kohno M
Nihon Rinsho; 2004 Mar; 62 Suppl 3():471-7. PubMed ID: 15171418
[No Abstract] [Full Text] [Related]
2. [Therapeutic perspectives: association of ACE inhibitors and angiotensin receptor blockers].
Costantino S; Millozzi F; Scarlata S
Clin Ter; 2001; 152(2):77-8. PubMed ID: 11441526
[No Abstract] [Full Text] [Related]
3. [Management of hypertensive patients with cardiovascular damage].
Tomiyama H; Takata Y; Yamashina A
Nihon Rinsho; 2004 Mar; 62 Suppl 3():612-6. PubMed ID: 15171444
[No Abstract] [Full Text] [Related]
4. [Organ protection by angiotensin II receptor blockers].
Kumagai H; Onami T; Takimoto C; Iigaya K; Saruta T
Nihon Rinsho; 2004 Mar; 62 Suppl 3():569-73. PubMed ID: 15171437
[No Abstract] [Full Text] [Related]
5. [Antihypertensive therapy: risk stratification in diabetes and cardiac diseases].
Baumgart P
MMW Fortschr Med; 2006 Mar; 148(11):57, 59-60. PubMed ID: 16612965
[No Abstract] [Full Text] [Related]
6. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
Dahlöf B
J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
[TBL] [Abstract][Full Text] [Related]
7. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Kjeldsen SE; Julius S
Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303
[TBL] [Abstract][Full Text] [Related]
8. Ventricular hypertrophy and hypertension: prognostic elements and implications for management.
Krauser DG; Devereux RB
Herz; 2006 Jun; 31(4):305-16. PubMed ID: 16810470
[TBL] [Abstract][Full Text] [Related]
9. [Left ventricular hypertrophy. Recent aspects of diagnosis and therapy].
Schmieder RE; Schneider MP
MMW Fortschr Med; 2002 Oct; 144(42):45-6. PubMed ID: 12533997
[No Abstract] [Full Text] [Related]
10. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
11. Role of losartan therapy in the management of diabetic hypertension.
Paul B; Sapra B; Maheshwari S; Goyal RK
J Assoc Physicians India; 2000 May; 48(5):514-8. PubMed ID: 11273147
[TBL] [Abstract][Full Text] [Related]
12. [Losartan, new angiotensin receptor antagonist--a challenge for enzyme converting angiotensin inhibitors?].
Chabielska E; Pawlak R
Wiad Lek; 1995; 48(1-12):242-5. PubMed ID: 9638249
[No Abstract] [Full Text] [Related]
13. [Therapy for hypertension associated with kidney disease].
Suzuki H
Nihon Naika Gakkai Zasshi; 2003 Feb; 92(2):264-9. PubMed ID: 12652731
[No Abstract] [Full Text] [Related]
14. Reduction in left ventricular hypertrophy in hypertensive patients treated with enalapril, losartan or the combination of enalapril and losartan.
Avanza AC; El Aouar LM; Mill JG
Arq Bras Cardiol; 2000 Feb; 74(2):103-17. PubMed ID: 10904284
[TBL] [Abstract][Full Text] [Related]
15. Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
Devereux RB; Dahlöf B
Curr Med Res Opin; 2007 Feb; 23(2):443-57. PubMed ID: 17288698
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II type 1 receptor blockade: a new development in cardiovascular pharmacology.
Leary AC; MacDonald TM
Int J Clin Pract; 1998 Oct; 52(7):475-81. PubMed ID: 10622089
[TBL] [Abstract][Full Text] [Related]
17. Redefining efficacy of antihypertensive therapies beyond blood pressure reduction--the role of angiotensin II antagonists.
Conlin PR
Int J Clin Pract; 2005 Feb; 59(2):214-24. PubMed ID: 15854200
[TBL] [Abstract][Full Text] [Related]
18. [Regression of left ventricular hypertrophy in hypertensive patients].
Bosa Ojeda F; García González M; Domínguez Rodríguez A; Barragán Acea A; Miralles Ibarra JM; Lacalzada Almeida J; de Armas Trujillo D
Rev Esp Cardiol; 1997; 50 Suppl 4():74-6. PubMed ID: 9411592
[TBL] [Abstract][Full Text] [Related]
19. The benefits of angiotensin II receptor blockers in patients with renal insufficiency or failure.
Venkata C; Ram S; Fierro G
Am J Ther; 1998 Mar; 5(2):101-5. PubMed ID: 10099045
[TBL] [Abstract][Full Text] [Related]
20. [Fewer cases of stroke, atrial fibrillation, diabetes and renal insufficiency. Good treatment of hypertension is more than lowering of blood pressure].
Baumgart P
MMW Fortschr Med; 2008 Jan; 150(1-2):52-3. PubMed ID: 18300647
[No Abstract] [Full Text] [Related]
[Next] [New Search]
